Brisbane, CA
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
revirtx.comThese are collections ReviR Therapeutics is a part of. Click on the collection name to view similar companies.
Grant
$4,618,687
Series A
$30,000,000
Seed
$20,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on ReviR Therapeutics.